Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123514533 | 12351453 | 3 | F | 20160121 | 20160718 | 20160510 | 20160722 | EXP | US-PFIZER INC-2016247604 | PFIZER | 80.00 | YR | F | Y | 63.50000 | KG | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123514533 | 12351453 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | 51201548 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 123514533 | 12351453 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 2X/DAY | A527301 | 21845 | 20 | MG | FILM-COATED TABLET | BID | ||||||
| 123514533 | 12351453 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 2X/DAY | A563501 | 21845 | 20 | MG | FILM-COATED TABLET | BID | ||||||
| 123514533 | 12351453 | 4 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 123514533 | 12351453 | 5 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 4 MG, DAILY | 0 | 4 | MG | ||||||||
| 123514533 | 12351453 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 123514533 | 12351453 | 7 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | Oral | 20 MG, 1X/DAY, (TAKES AT NIGHT) | 0 | 20 | MG | TABLET | QD | ||||||
| 123514533 | 12351453 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 123514533 | 12351453 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 123514533 | 12351453 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | 5MG TABLET, 1/2 TABLET DAILY | 0 | 2.5 | MG | TABLET | ||||||||
| 123514533 | 12351453 | 11 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, 2X/DAY, (ONE TABLET BY MOUTH IN THE MORNING AND ONE AT 2:00 IN THE AFTERNOON) | 0 | 50 | MG | TABLET | BID | ||||||
| 123514533 | 12351453 | 12 | C | DIGOXIN. | DIGOXIN | 1 | 125MG TABLET EVERY OTHER DAY | 0 | 125 | MG | TABLET | QOD | |||||||
| 123514533 | 12351453 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 100 MG, DAILY, (60MG IN THE MORNING AND 40MG IN THE AFTERNOON) | 0 | 100 | MG | TABLET | |||||||
| 123514533 | 12351453 | 14 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 88 UG, 1X/DAY | 0 | 88 | UG | TABLET | QD | ||||||
| 123514533 | 12351453 | 15 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 50 UG, DAILY | 0 | 50 | UG | TABLET | |||||||
| 123514533 | 12351453 | 16 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, DAILY (10 MG PILL, 1/2 TABLETS DAILY | 0 | 5 | MG | TABLET | |||||||
| 123514533 | 12351453 | 17 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG PILL 1/2 PILL EVERY OTHER DAY | 0 | 5 | MG | TABLET | QOD | ||||||
| 123514533 | 12351453 | 18 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 400 MG, 1X/DAY | 0 | 400 | MG | CAPSULE | QD | |||||||
| 123514533 | 12351453 | 19 | C | OXYGEN. | OXYGEN | 1 | 3 L, 24/7 | 0 | 3 | L | |||||||||
| 123514533 | 12351453 | 20 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 123514533 | 12351453 | 21 | C | WARFARIN | WARFARIN | 1 | Oral | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | TABLET | QD | ||||||
| 123514533 | 12351453 | 22 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | 0.4 MG, AS NEEDED | 0 | .4 | MG | ||||||||
| 123514533 | 12351453 | 23 | C | BUDESONIDE. | BUDESONIDE | 1 | UNK, 2X/DAY, (AT 9:00AM AND AT NIGHT) | 0 | BID | ||||||||||
| 123514533 | 12351453 | 24 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.63 MG, AS NEEDED | 0 | .63 | MG | |||||||||
| 123514533 | 12351453 | 25 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 20 MG PILL 1 PILL ONCE DAILY, TAKES AT NIGHT | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123514533 | 12351453 | 1 | Pulmonary hypertension |
| 123514533 | 12351453 | 5 | Prophylaxis |
| 123514533 | 12351453 | 7 | Blood cholesterol |
| 123514533 | 12351453 | 8 | Abdominal discomfort |
| 123514533 | 12351453 | 9 | Gout |
| 123514533 | 12351453 | 11 | Heart rate |
| 123514533 | 12351453 | 12 | Cardiac disorder |
| 123514533 | 12351453 | 13 | Fluid imbalance |
| 123514533 | 12351453 | 14 | Thyroid disorder |
| 123514533 | 12351453 | 16 | Pain in extremity |
| 123514533 | 12351453 | 17 | Dyspnoea |
| 123514533 | 12351453 | 18 | Blood magnesium decreased |
| 123514533 | 12351453 | 19 | Atrial fibrillation |
| 123514533 | 12351453 | 20 | Dyspnoea |
| 123514533 | 12351453 | 21 | Transient ischaemic attack |
| 123514533 | 12351453 | 22 | Chest pain |
| 123514533 | 12351453 | 23 | Dyspnoea |
| 123514533 | 12351453 | 24 | Dyspnoea |
| 123514533 | 12351453 | 25 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123514533 | 12351453 | OT |
| 123514533 | 12351453 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123514533 | 12351453 | Cardiac failure congestive | |
| 123514533 | 12351453 | Peripheral coldness | |
| 123514533 | 12351453 | Pneumonia | |
| 123514533 | 12351453 | Poor peripheral circulation | |
| 123514533 | 12351453 | Tendonitis | |
| 123514533 | 12351453 | Thrombosis | |
| 123514533 | 12351453 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123514533 | 12351453 | 1 | 20120803 | 0 | ||
| 123514533 | 12351453 | 18 | 201603 | 0 |